What did @codyontrt actually say?
At week 22 of testosterone replacement therapy, Cody shared his bloodwork: total testosterone at 904 ng/dL, free testosterone at 198 pg/mL, and estradiol at 61 pg/mL. He noted his pre-TRT total testosterone was around 260 ng/dL. He flagged the estrogen as "definitely high" but said he feels no symptoms from it, and plans to discuss it with his clinic doctor. That's a reasonably responsible approach, and the self-awareness about estrogen is worth acknowledging.
His framing was personal and anecdotal, not prescriptive. He didn't recommend a dose or tell viewers to replicate his protocol. That matters when evaluating how potentially harmful this content actually is.
Does the science back this up?
Mostly, yes, with one significant caveat around the estrogen number. Total testosterone at 904 ng/dL sits comfortably within the therapeutic target range most endocrinology guidelines aim for. Free testosterone at 198 pg/mL is on the higher end but not alarming in isolation. The estradiol reading deserves more serious attention than Cody gave it.
The Endocrine Society's clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) define a normal male estradiol range as roughly 10-40 pg/mL. At 61 pg/mL, Cody is meaningfully above that. Elevated estradiol in men on TRT is associated with gynecomastia, fluid retention, and in some research, cardiovascular and mood effects. A study by Finkelstein et al. (2013, New England Journal of Medicine) demonstrated that estrogen plays a complex role in male physiology, including bone density and libido, so blanket suppression isn't the answer. But 61 pg/mL warrants a real clinical conversation, not just a shrug because symptoms haven't appeared yet.
What did they get wrong (or right)?
Cody got the general self-monitoring right. Getting bloodwork done at week 22 and tracking total testosterone, free testosterone, and estradiol is exactly what responsible TRT use looks like. His pre-TRT baseline of around 260 ng/dL is consistent with clinical hypogonadism, which typically requires a threshold below 300 ng/dL for diagnosis (Bhasin et al., 2018).
Where he undersells the issue is the line "I don't feel any negatives from that high estrogen." This is a common and genuinely risky assumption. Symptoms of elevated estradiol, particularly cardiovascular strain and early gynecomastia, are not always immediately apparent. A paper by Laughlin et al. (2008, American Journal of Epidemiology) found that both low and high estradiol in men correlated with increased mortality risk, which is not a reason to panic, but it is a reason to not dismiss a number of 61 pg/mL simply because you feel fine today. Feeling fine is not a biomarker.
What should you actually know?
If you're on TRT and watching this video for guidance, here's what actually matters. First, your bloodwork timing is everything. Cody tested three days post-injection, which captures a near-peak reading for cypionate or enanthate. Testing at trough, closer to injection day, gives a different picture. Neither is wrong, but your clinic needs to know when in your cycle you tested.
Second, estradiol at 61 pg/mL is not a medical emergency, but it is a signal. Aromatase inhibitors are sometimes used to manage this, but they carry their own risks, including over-suppression that tanks estrogen too far, which also causes problems (Finkelstein et al., 2013). This is genuinely a conversation for a prescribing clinician, not a TikTok comment section.
Third, the absence of symptoms does not equal the absence of risk. This is the single most important thing to understand about hormonal management. Bloodwork exists precisely because the body compensates quietly before it doesn't.
- Total testosterone of 904 ng/dL is within accepted therapeutic range for treated hypogonadism.
- Estradiol at 61 pg/mL exceeds standard male reference ranges and warrants clinical evaluation.
- Symptom-free does not confirm a safe hormonal state, especially for cardiovascular markers.
- Testing timing relative to injection cycle significantly affects how results should be interpreted.
Bottom line: should you take anything from this video?
Cody's video is more responsible than most TRT content on TikTok. He shares real numbers, acknowledges a potential problem, and defers to a doctor rather than self-medicating. That's a lower bar than it should be, but he clears it. The concern is that viewers might absorb the "I feel fine so it's fine" framing about elevated estradiol and apply it to their own situations without the same follow-through. Feeling good at week 22 is not a clean bill of health. It's a starting point for the conversation he says he's going to have.